Results 21 to 30 of about 550,140 (248)

Sostoyanie serdtsa po dannym ekhokardiografiiu lits s ozhireniem, manifestirovavshimv pubertatnyy period

Ожирение и метаболизм, 2011
47 male patients were included in this study: the group of 17 adolescents with puberty-onset obesity (aged 19,7±0,37 years), the group of 20 adults with puberty-onset obesity (aged 32,25±0,96 years), 10 gender-matched controls (aged 20,8±0,25 years). All

doaj   +1 more source

Myocardial fibrosis as an early manifestation of hypertrophic cardiomyopathy [PDF]

, 2010
BACKGROUND: Myocardial fibrosis is a hallmark of hypertrophic cardiomyopathy and a proposed substrate for arrhythmias and heart failure. In animal models, profibrotic genetic pathways are activated early, before hypertrophic remodeling.
Cirino, A.L. (Alison L.), Coelho-Filho, O.R. (Otavio R.), Colan, S.D. (Steven D.), Diez-Martinez, J. (Javier), Gonzalez, A. (Arantxa), Ho, C.Y. (Carolyn Y.), Jarolim, P. (Petr), Kwong, R.Y. (Raymond Y.), Lakdawala, N.K. (Neal K.), Lopez-Salazar, M.B. (María Begoña), Seidman, C.E. (Christine E.), Seidman, J.G. (J.G.)   +11 more
core   +1 more source

Cardiac hypertrophy and heart failure: from the case to review of literature [PDF]

, 2016
In response to an increased workload due to physiological or pathological stimuli, the heart may undergo a process of growth with increased muscle mass called cardiac hypertrophy. It is a particular mechanism of long term compensation used by the heart
Massoni, Francesco, Onofri, Emanuela, Ricci, Lidia, Ricci, Serafino, Simeone, Claudio   +4 more
core   +1 more source

Association of obesity phenotypes with left ventricular mass index and left ventricular hypertrophy in children and adolescents

Frontiers in Endocrinology, 2022
It has been argued that metabolically healthy obesity (MHO) does not increase the risk of cardiovascular disease. The aim of this study is to evaluate whether, in a population of obese children/adolescents, the metabolically unhealthy obesity (MUO ...
Simonetta Genovesi, Simonetta Genovesi, Elena Tassistro, Marco Giussani, Giulia Lieti, Ilenia Patti, Antonina Orlando, Massimo Montemerlo, Laura Antolini, Gianfranco Parati, Gianfranco Parati   +10 more
doaj   +1 more source

Possible predicative role of electrical risk score on transcatheter aortic valve replacement outcomes in older patients. preliminary data [PDF]

, 2018
Background:Transcatheter aortic valve replacement (TAVR) is an effective procedure capable to change the natural history of the degenerative aortic valve stenosis.
DI IORIO, Claudia, Fabietti, Marcella, Magri', Damiano, Mancone, Massimo, Mariani, MARCO VALERIO, Mastropietri, Fabiola, Moscucci, Federica, Parrotta, Ilaria, Piccirillo, Gianfranco, Sardella, Gennaro   +9 more
core   +1 more source

The Gene Polymorphism of Angiotensin-Converting Enzyme Intron Deletion and Angiotensin-Converting Enzyme G2350A in Patients With Left Ventricular Hypertrophy: A Meta-analysis

Indian Heart Journal, 2019
Objectives: The aim of the study was to evaluate the correlation between left ventricular hypertrophy and the gene polymorphism of angiotensin-converting enzyme (ACE) intron deletion (I/D) and ACE G2350A.
Jonny Karunia Fajar, Budi Susetio Pikir, Erdo Puncak Sidarta, Putu Nina Berlinda Saka, Rizal Rahmanda Akbar, Teuku Heriansyah   +5 more
doaj   +1 more source

Soluble ST2 levels and left ventricular structure and function in patients with metabolic syndrome [PDF]

, 2016
Background: A biomarker that is of great interest in relation to adverse cardiovascular events is soluble ST2 (sST2), a member of the interleukin family.
Beunza, Maite, Cardelli, Patrizia, Celic, Vera, Di Somma, Salvatore, Escribano, Elena, Floridi, Federico, Lopez-Andres, Natalia, Magrini, Laura, Majstorovic, Anka, Marino, Rossella, Melero, Amaia, Pencic-Popovic, Biljana, Roy, Ignacio, Salerno, Gerardo, Sljivic, Aleksandra   +14 more
core   +1 more source

FGF23/FGFR4-mediated left ventricular hypertrophy is reversible

Scientific Reports, 2017
Fibroblast growth factor (FGF) 23 is a phosphaturic hormone that directly targets cardiac myocytes via FGF receptor (FGFR) 4 thereby inducing hypertrophic myocyte growth and the development of left ventricular hypertrophy (LVH) in rodents.
A. Grabner, K. Schramm, N. Silswal, Matt Hendrix, Christopher Yanucil, Brian Czaya, S. Singh, M. Wolf, S. Hermann, J. Stypmann, G. D. Di Marco, M. Brand, M. Wacker, C. Faul   +13 more
semanticscholar   +1 more source

Left ventricular hypertrophy in children, adolescents and young adults with sickle cell anemia

Revista Brasileira de Hematologia e Hemoterapia, 2015
OBJECTIVE: The aims of this study were to estimate the frequency of left ventricular hypertrophy and to identify variables associated with this condition in under 25-year-old patients with sickle cell anemia.METHODS: A cross-sectional study was performed
Gustavo Baptista de Almeida Faro, Osvaldo Alves Menezes-Neto, Geodete Santos Batista, Antônio Pereira Silva-Neto, Rosana Cipolotti   +4 more
doaj   +1 more source

Ventricular androgenic-anabolic steroid-related remodeling: an immunohistochemical study [PDF]

, 2017
Background: Several fatal cases of bodybuilders, following a myocardial infarction after long exposure to androgenicanabolic steroids (AAS), are reported. In recent years, evidence has emerged of cases of heart failure related to AAS consumption, with no
Cecchi, Rossana, Ciallella, Costantino, DI LUCA, Natale Mario, Kimura, Akihiko, Kondo, Toshikazu, Muciaccia, Barbara, Nosaka, Mizuho, Sestili, Cristina   +7 more
core   +1 more source